3Patrono C, Coller B, Fitz Gerald GA, et al. Platelet - active drugs : the relationships among does, effectiveness, and side effects: the Seventh ACCP on Antlthrombotlc and Thrombolytic Therapy. Chest ,2004,126 (3 Suppl) :234S.
4Roll, PJ, et al, The structural basis of aspirin activity inferred from the crystal structure of inactivated prostaglandin H2 synthase. Nature Structural biology, 1995,2:637.
5Jimenez AH, et al, Rapidity and duration of platelet suppression by enteric-coated aspirin in healthy young man. Am J Cardiol, 1992, 69:258.
6Bode - Boger SM. Zur kardiovakularen pretektion mit Aspirin(ASS). Deutsehes Arzteblatt, 1993,90AI : 1894.
7Hermide RC. influence of aspirin usage on blood pressure : does and administration- time dependencies. Chronobiology International, 1997,14:619.
8Hermide RC. Time - dependent effects of low - does aspirin administration on blood pressure in pregnant women. Hypertension, 1997,30: 589.
9Ross R. Atherosclerosis - an inflammatory disease. N Eng J Meal, 1999,340:115.
10Ridker PM. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Eng J Med,1997 ,336 :973.
